Form 4 for PCVX Vaxcyte, Inc.

Accepted 2025-09-04 00:00:00 ET · period of report 2025-09-02 · accession 0001813798-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-09-04	2025-09-02	PCVX	Wassil Jim	COO	F - Tax	$31.56	-4,286	146.3K	-3%	-$135.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-09-02	F	D	1,270	$31.56	149,286	D	—	—	(F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. (F3) Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025. (F2) The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. On April 1, 2025, the Reporting Person transferred 1,689 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings.
2	Common	Common Stock	2025-09-02	F	D	1,587	$31.56	147,699	D	—	—	(F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
3	Common	Common Stock	2025-09-02	F	D	1,429	$31.56	146,270	D	—	—	(F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.